Article

NYU Langone Leadership Page

https://nyulangone.org/news/international-expert-cornea-ocular-diseases-lead-department-ophthalmology-nyu-langone-health

https://nyulangone.org/news/renowned-eye-surgeon-named-vice-chair-ophthalmology-education-director-cornea-service-nyu-langone-health

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Ophthalmology Times: Kathryn Colby, MD, PhD, reflects on National Women Physicians Day
Ronald Zombrano
Related Content
Kathryn Colby from NYU Langone gives insight into AI Optics Sentinel Camera
January 31st 2025

Kathryn Colby from NYU Langone gives insight into AI Optics Sentinel Camera

Advancing Fuchs dystrophy care: Longterm success of descemet stripping only
December 26th 2024

Advancing Fuchs dystrophy care: Longterm success of descemet stripping only

Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies
Published: December 26th 2024 | Updated: December 26th 2024

Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies

NYU Grossman School of Medicine launches Journal Club series with expert insights on ophthalmology research
December 26th 2024

NYU Grossman School of Medicine launches Journal Club series with expert insights on ophthalmology research

NYU Langone receives $1.6 million grant from NIH to study Alzheimer, Parkinson progression
October 3rd 2024

NYU Langone receives $1.6 million grant from NIH to study Alzheimer, Parkinson progression

The world's first whole-eye and partial-face transplant recipient continues recovery with viable eye 1 year after landmark surgery
September 10th 2024

The world's first whole-eye and partial-face transplant recipient continues recovery with viable eye 1 year after landmark surgery

© 2025 MJH Life Sciences

All rights reserved.